These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 11555157)

  • 1. Levamisole and/or Chinese medicinal herbs can modulate the serum level of squamous cell carcinoma associated antigen in patients with erosive oral lichen planus.
    Sun A; Chiang CP
    J Oral Pathol Med; 2001 Oct; 30(9):542-8. PubMed ID: 11555157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum interleukin-6 level is a useful marker in evaluating therapeutic effects of levamisole and Chinese medicinal herbs on patients with oral lichen planus.
    Sun A; Chia JS; Chang YF; Chiang CP
    J Oral Pathol Med; 2002 Apr; 31(4):196-203. PubMed ID: 12076322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Levamisole and Chinese medicinal herbs can modulate the serum interleukin-6 level in patients with recurrent aphthous ulcerations.
    Sun A; Chia JS; Chang YF; Chiang CP
    J Oral Pathol Med; 2003 Apr; 32(4):206-14. PubMed ID: 12653859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Levamisole can reduce the high serum tumour necrosis factor-alpha level to a normal level in patients with erosive oral lichen planus.
    Sun A; Chia JS; Wang JT; Chiang CP
    Clin Exp Dermatol; 2007 May; 32(3):308-10. PubMed ID: 17397355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of serum antinuclear antibody levels by levamisole treatment in patients with oral lichen planus.
    Lin HP; Wang YP; Chia JS; Sun A
    J Formos Med Assoc; 2011 May; 110(5):316-21. PubMed ID: 21621152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of serum smooth muscle antibody levels by levamisole treatment in patients with oral lichen planus.
    Wu KM; Wang YP; Lin HP; Chen HM; Chia JS; Sun A
    J Formos Med Assoc; 2013 Jun; 112(6):352-7. PubMed ID: 23602020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum interleukin-8 level is a more sensitive marker than serum interleukin-6 level in monitoring the disease activity of oral lichen planus.
    Sun A; Wang JT; Chia JS; Chiang CP
    Br J Dermatol; 2005 Jun; 152(6):1187-92. PubMed ID: 15948980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SCCA, TSGF, and the Long Non-Coding RNA AC007271.3 are Effective Biomarkers for Diagnosing Oral Squamous Cell Carcinoma.
    Shao T; Huang J; Zheng Z; Wu Q; Liu T; Lv X
    Cell Physiol Biochem; 2018; 47(1):26-38. PubMed ID: 29763905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of serum anti-thyroglobulin and anti-thyroid microsomal autoantibody levels by levamisole in patients with oral lichen planus.
    Lin HP; Wang YP; Chia JS; Sun A
    J Formos Med Assoc; 2011 Mar; 110(3):169-74. PubMed ID: 21497280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prompt healing of erosive oral lichen planus lesion after combined corticosteroid treatment with locally injected triamcinolone acetonide plus oral prednisolone.
    Kuo RC; Lin HP; Sun A; Wang YP
    J Formos Med Assoc; 2013 Apr; 112(4):216-20. PubMed ID: 23537868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies of the serum HER-2/neu and squamous cell carcinoma-related antigen expression in patients with oral squamous cell carcinoma.
    Chen CH; Tsai TL; Yang YS; Tsai CC
    J Oral Pathol Med; 2007 Feb; 36(2):83-7. PubMed ID: 17238969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytokines and tumor markers in potentially malignant disorders and oral squamous cell carcinoma: a pilot study.
    Czerninski R; Basile JR; Kartin-Gabay T; Laviv A; Barak V
    Oral Dis; 2014 Jul; 20(5):477-81. PubMed ID: 23859102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Levamisole can modulate the serum tumor necrosis factor-alpha level in patients with recurrent aphthous ulcerations.
    Sun A; Wang JT; Chia JS; Chiang CP
    J Oral Pathol Med; 2006 Feb; 35(2):111-6. PubMed ID: 16430742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunomodulation by levamisole in patients with recurrent aphthous ulcers or oral lichen planus.
    Sun A; Chiang CP; Chiou PS; Wang JT; Liu BY; Wu YC
    J Oral Pathol Med; 1994 Apr; 23(4):172-7. PubMed ID: 7913970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum SCCA, Cyfra 21-1, EGFR and Cyclin D1 levels in patients with oral squamous cell carcinoma.
    Feng XY; Li JH; Li JZ; Han ZX; Xing RD
    Int J Biol Markers; 2010; 25(2):93-8. PubMed ID: 20586028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monitoring carcinogenesis in a case of oral squamous cell carcinoma using a panel of new metabolic blood biomarkers as liquid biopsies.
    Grimm M; Hoefert S; Krimmel M; Biegner T; Feyen O; Teriete P; Reinert S
    Oral Maxillofac Surg; 2016 Sep; 20(3):295-302. PubMed ID: 26875085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anemia and hematinic deficiencies in gastric parietal cell antibody-positive and antibody-negative erosive oral lichen planus patients with thyroid antibody positivity.
    Chang JY; Chen IC; Wang YP; Wu YH; Chen HM; Sun A
    J Formos Med Assoc; 2016 Nov; 115(11):1004-1011. PubMed ID: 27802920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Response to levamisole and low-dose prednisolone in 41 patients with chronic oral ulcers: a 3-year open clinical trial and follow-up study.
    Lu SY; Chen WJ; Eng HL
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1998 Oct; 86(4):438-45. PubMed ID: 9798228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hematinic deficiencies and anemia statuses in anti-gastric parietal cell antibody-positive or all autoantibodies-negative erosive oral lichen planus patients.
    Chang JY; Wang YP; Wu YH; Su YX; Tu YK; Sun A
    J Formos Med Assoc; 2018 Mar; 117(3):227-234. PubMed ID: 29292055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of tumor markers in patients with squamous cell carcinoma in the oral cavity.
    Kurokawa H; Tsuru S; Okada M; Nakamura T; Kajiyama M
    Int J Oral Maxillofac Surg; 1993 Feb; 22(1):35-8. PubMed ID: 7681461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.